Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Oct 08
 +0.07 / +0.14%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month-17.45% 3 years+20.30%
3 months-21.86% 5 years+19.57%
1 year-4.12% Since inception+14.92%
Data through 10/09/2015

Quote Details

Previous close$48.38
Open day’s range47.00 – 48.71
Net asset value (NAV)48.48 (10/08/2015)
Daily volume182,755
Average volume (3 months)224,567
Data as of 10/08/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return+19.57%+20.45%
Expense Gross exp ratio0.35%0.46%
Risk 5 year sharpe ratio1.061.31
Net assets$802.9M$1.7B
Average market cap$4.3B$33.2B
Average P/E24.324.4
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ITCI Intra-Cellular Therapies Inc4.16%
LLY Eli Lilly and Co3.38%
JNJ Johnson & Johnson3.32%
BMY Bristol-Myers Squibb3.30%
PFE Pfizer3.15%
MRK Merck3.13%
ENDP Endo International PLC3.06%
AGN Allergan3.04%
ZTS Zoetis Inc3.02%
NKTR Nektar Therapeutics2.96%

Partner Offers